![Abstract 2634: Warfarin INR-Response Curves in Subgroups of Patients with Nonvalvular Atrial Fibrillation: Should Target Anticoagulation Intensity be Adjusted for Patient Characteristics?: The ATRIA Study | Circulation Abstract 2634: Warfarin INR-Response Curves in Subgroups of Patients with Nonvalvular Atrial Fibrillation: Should Target Anticoagulation Intensity be Adjusted for Patient Characteristics?: The ATRIA Study | Circulation](https://www.ahajournals.org/cms/asset/111c0ef9-7878-4dc7-b3a7-272e1a57a553/2634f1.jpg)
Abstract 2634: Warfarin INR-Response Curves in Subgroups of Patients with Nonvalvular Atrial Fibrillation: Should Target Anticoagulation Intensity be Adjusted for Patient Characteristics?: The ATRIA Study | Circulation
![A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome | NEJM A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2003/nejm_2003.349.issue-12/nejmoa035241/production/images/img_medium/nejmoa035241_t1.jpeg)
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome | NEJM
![Comparison of warfarin dosage needed to achieve target INR before and after cardiac surgery - The British Journal of Cardiology Comparison of warfarin dosage needed to achieve target INR before and after cardiac surgery - The British Journal of Cardiology](https://bjcardio.co.uk/wp-content/uploads/2016/01/table-14.png)
Comparison of warfarin dosage needed to achieve target INR before and after cardiac surgery - The British Journal of Cardiology
SimpleNursing - 𝐇𝐞𝐩𝐚𝐫𝐢𝐧 𝐯𝐬 𝗪𝐚𝐫𝐟𝐚𝐫𝐢𝐧 𝐇𝐞𝐩𝐚𝐫𝐢𝐧: Therapeutic Range 46 – 70 PTT Memory Trick: “HePTT” the frog H – Heparin P – Protamine Sulfate (Antidote) PTT– 46 – 70 Max
![Frontiers | Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin Frontiers | Pharmaceutical Care Increases Time in Therapeutic Range of Patients With Poor Quality of Anticoagulation With Warfarin](https://www.frontiersin.org/files/MyHome%20Article%20Library/404968/404968_Thumb_400.jpg)